Disulfiram toxicity and carbon disulfide poisoning

Autor: Rainey Jm

Publikováno v: The American journal of psychiatry. 134(4)

The author compared the neurotoxic effects of disulfiram with those of carbon disulfide, a disulfiram metabolite. The results suggest that carbon disulfide is responsible for the behavioral and neurological side effects of disulfiram. If this is so,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c54d416fd26ac48b55ec3597572f65
https://pubmed.ncbi.nlm.nih.gov/190907

'Simone's OncOpinion' on the Death of NCCN Medical Director Christopher Desch, MD (1/25/07) (second letter)

Autor: Rainey JM

Publikováno v: Oncology Times; 2007 Mar 10, Vol. 29 Issue 5, p3-3, 1p

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Autor: Schiffer CA; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Bohlke K; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Delaney M; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Hume H; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Magdalinski AJ; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., McCullough JJ; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Omel JL; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rainey JM; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rebulla P; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Rowley SD; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Troner MB; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Anderson KC; Charles A. Schiffer, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; Kari Bohlke, American Society of Clinical Oncology, Alexandria, VA; Meghan Delaney, Children's National Medical System & George Washington University, Washington DC; Heather Hume, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Anthony J. Magdalinski, Alliance Cancer Specialists, Sellersville, PA; Jeffrey J. McCullough, University of Minnesota, Minneapolis, MN; James L. Omel, Patient Representative, Grand Island, NE; John M. Rainey, University Health Center, Lafayette, LA; Paolo Rebulla, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Scott D. Rowley, Hackensack University Medical Center, Hackensack, NJ; Michael B. Troner, Miami Cancer Institute, Miami, FL; and Kenneth C. Anderson, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Jan 20; Vol. 36 (3), pp. 283-299. Date of Electronic Publication: 2017 Nov 28.

Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2).

Autor: Rinaldi DA; Louisiana Oncology Associates, 501 West St. Mary Boulevard, Suite 200, Lafayette, LA 70506, USA., Lormand NA, Brierre JE, Cole JL, Stagg MP, Fontenot MF, Buller EJ, Rainey JM

Publikováno v: American journal of clinical oncology [Am J Clin Oncol] 2002 Oct; Vol. 25 (5), pp. 523-7.

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Autor: Schiffer CA; Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit MI, USA., Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2001 Mar 01; Vol. 19 (5), pp. 1519-38.